🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

After you register, don't forget to sign up for our BCM Clinician Resources monthly newsletter which features talks/ events like this! No FOMO. clinicianresources.bcm.edu/about/newslett… (Open to physicians everywhere) Ruben Hernaez Reena Chokshi, MD Kavish Patidar Frederick Peng, M.D. Texas Society for Gastroenterology and Endoscopy Mimi Tan

Association of HRS-AKI with Mortality in Patients with... : Kidney360 journals.lww.com/kidney360/abst…

In this mixed-methods study of 372 transplant-ineligible patients with cirrhosis w/ severe AKI (ATN or HRS), we found that ~1 in 6 of those who received RRT were alive in 6 months - work led by Paige McLean Diaz in Digestive Diseases and Sciences #palliativehepatology #ACLF

Kavish Patidar breaking ground research presented AASLD Healio Gastroenterology BCM Gastroenterology -way to go! healio.com/news/hepatolog…

Hear from Kavish Patidar of BCMHouston as he discusses the impact of country-level socioeconomic status and healthcare delivery on acute #kidney injury outcomes in patients with #cirrhosis. hcplive.com/view/country-l…

Kickstarting the inaugural GLOBAL LIVER SAFETY EXPERTS @cancun with THE expert Naga Chalasani avantsantemx Raj VuppaLanchi Eric S Orman MD MSCR Lily Dara Craig Lammert, MD

Kavish Patidar Adam Myer MD Elliot Tapper Giuseppe Cullaro ⏰ Early treatment of HRS-AKI is key, but how early is too early? Facts: 1️⃣volume responsive AKI is 3x more common than HRS-AKI 2️⃣HRS-AKI patients have effective hypovolemia by definition ➡️volume challenge is essential 3️⃣central volume overload? Terlipressin is not an option

TCorticosteroids in severe alcohol-associated hepatitis? Not so fast! Avegail Flores HEPATOLOGY Journal Ramon Bataller Fasiha Kanwal Juan Pablo (JP) Arab, MD  George Cholankeril Kavish Patidar Fasiha Kanwal Howard T. Lee MD FAST Vijay Shah Maya Balakrishnan Sumeet Asrani tinyurl.com/2kzac7r8

Check out our latest article. Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: A randomized, single-blind clinical trial - JHEP Reports jhep-reports.eu/article/S2589-… JHEP Reports EASLnews The Baveno Cooperation: an EASL Consortium LiverUnit.Clinic.BCN

📣Global Aki published in The Lancet Gastroenterology & Hepatology 🗺️3,821 patients with cirrhosis ✅38% had AKI ⚠️discrepancies in AKI management and outcomes ⚠️ AKI ➡️22.9% 28-day mortality 🎯Need for equitable & standardized care thelancet.com/journals/langa…

Artículo Original Corticosteroides en la hepatitis asociada a alcohol severa: No tan rápido: Una revisión sistemática de ensayos controlados aleatorizados. Shi, Pungwe et al. #LiverX tinyurl.com/mzzk8uar

Original Article Acute encephalopathy without hyperammonemia has a different presentation than overt HE and displays a similarly severe prognosis Desplats et al. #LiverX tinyurl.com/265wwdeh

💬 on a✈️ to 📝 with Anand V Kulkarni 🔸So we all 🗣️AKI in CLD 🔸But ⁉️ESRD with ascites on consults (and they aren't uncommon) 🔸We dig deep -SAAG 🚫 -Causes: Mixed bag -Nephrogenic ascites 📈 ☠️ - 💊❓ Large gaps in 📝 Elliot Tapper Liver Fellow Network AASLD journals.lww.com/hepcomm/fullte…

The jefe! My go to for anything related to methods and analysis plan. 🔥Liver risk score predicts liver related events with excellent performance in a diverse US veteran population.

📣New data on cirrhosis recompensation in Journal of Hepatology ✅Only 7% meets strict Baveno VII criteria ✅Expanded criteria capture ~38% with similar low mortality risk Recompensation: ⬇️systemic inflammation🔥 👍 improved hemodynamic ⬆️improved survival doi.org/10.1016/j.jhep…